Audit® MicroLQ™ Serum Protein Control is an assayed, ready-to-use liquid, bi-level, human serum -based control for use with assays designed to quantitate: Immunoglobulin E (IgE), Immunoglobulin M (IgM), Immunoalobulin G (IgG), Immunoqlobulin A (IgA), Prealbumin, Antithrombin III. Alpha-1-Antitrypsin (AAT). Albumin. Complement C4 (C4). Complement C3 (C3), alpha-2-Macroglobulin, Alpha-1-Acid Glycoprotein, Ceruloplasmin, Transferrin, Haptoglobin, and Beta-2-Microglobulin. It is intended to simulate human patient samples for the purpose of monitoring the precision of laboratory testing procedures for Immunoglobulin E (IgE), Immunoglobulin M (IgM), Immunoglobulin G (IgG), Immunoglobulin A (IgA), Prealbumin, Antithrombin III, Alpha-1-Antitrypsin (AAT), Albumin, Complement C4 (C4), Complement C3 (C3), alpha-2-Macroglobulin, Alpha-1-Acid Glycoprotein, Ceruloplasmin, Transferrin, Haptoglobin, and Beta-2-Microglobulin assays. When used for quality control purposes, it is recommended that each laboratory establish its own means and acceptable ranges and use the values provided only as guides. The product is intended for use with quantitative assays on the Beckman Immage 800. The Audit® MicroLQ™ Serum Protein Control is for In Vitro Diagnostic use only.
Device Story
Audit® MicroLQ™ Serum Protein Control is a human serum-based, liquid, bi-level quality control material. It contains 16 specific analytes, including various immunoglobulins, complement proteins, and transport proteins. The device is used in clinical laboratories to monitor the precision of quantitative assays performed on the Beckman Immage 800 analyzer. By simulating human patient samples, the control allows laboratory personnel to verify that testing procedures are performing within established acceptable ranges. It does not perform analysis itself; rather, it serves as a reference material to detect systematic analytical deviations. Healthcare providers use the resulting quality control data to ensure the accuracy and reliability of patient test results, thereby supporting clinical decision-making.
Clinical Evidence
No clinical data. Bench testing only. Value assignment performed on Beckman Immage 800 analyzer using 15 measurements over three days to establish target means. Target ranges calculated as ±15% of target value. Stability established via accelerated stability study (30 days stress) with confirmatory real-time testing ongoing.
Technological Characteristics
Human serum-based liquid control; bi-level; contains 16 analytes (IgE, IgM, IgG, IgA, Prealbumin, Antithrombin III, AAT, Albumin, C4, C3, alpha-2-Macroglobulin, Alpha-1-Acid Glycoprotein, Ceruloplasmin, Transferrin, Haptoglobin, Beta-2-Microglobulin). Storage at 2-8°C. Open-bottle stability of 36 months at 2-8°C.
Indications for Use
Indicated for use as an assayed, bi-level, human serum-based quality control material to monitor the precision of laboratory testing procedures for 16 specific serum protein analytes (IgE, IgM, IgG, IgA, Prealbumin, Antithrombin III, AAT, Albumin, C4, C3, alpha-2-Macroglobulin, Alpha-1-Acid Glycoprotein, Ceruloplasmin, Transferrin, Haptoglobin, and Beta-2-Microglobulin) on the Beckman Immage 800 analyzer.
Regulatory Classification
Identification
A quality control material (assayed and unassayed) for clinical chemistry is a device intended for medical purposes for use in a test system to estimate test precision and to detect systematic analytical deviations that may arise from reagent or analytical instrument variation. A quality control material (assayed and unassayed) may be used for proficiency testing in interlaboratory surveys. This generic type of device includes controls (assayed and unassayed) for blood gases, electrolytes, enzymes, multianalytes (all kinds), single (specified) analytes, or urinalysis controls.
Predicate Devices
Audit® MicroCV™ Protein Linearity Set (k101216)
Submission Summary (Full Text)
{0}
1
# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY
A. 510(k) Number:
k112705
B. Purpose for Submission:
New device
C. Measurand:
Quality control material for Immunoglobulin E (IgE), Immunoglobulin M (IgM), Immunoglobulin G (IgG), Immunoglobulin A (IgA), Prealbumin, Antithrombin III, Alpha-1-antitrypsin (AAT), Albumin, Complement C4 (C4), complement C3 (C3), Alpha-2-macroglobulin, Alpha-1-acid glycoprotein, Ceruloplasmin, Transferrin, Haptoglobin, and Beta-2-microglobulin
D. Type of Test:
Quality control material
E. Applicant:
Aalto Scientific Ltd.
F. Proprietary and Established Names:
Audit® MicroLQ™ Serum Protein Control
G. Regulatory Information:
1. Regulation section:
21 CFR §862.1660, Quality control material (assayed and unassayed)
2. Classification:
Class I
3. Product code:
JJY, Multi-analyte controls, all kinds (assayed)
4. Panel:
Clinical Chemistry (75)
H. Intended Use:
1. Intended use(s):
Audit® MicroLQ™ Serum Protein Control is an assayed, ready-to-use liquid, bi-level human serum-based control for use with assays designed to quantitate: Immunoglobulin E (IgE), Immunoglobulin M (IgM), Immunoglobulin G (IgG), Immunoglobulin A (IgA), Prealbumin, Antithrombin III, Alpha-1-Antitrypsin (AAT), Albumin, Complement C4 (C4), Complement C3 (C3), alpha-2-Macroglobulin, Alpha-1-Acid Glycoprotein, Ceruloplasmin, Transferrin, Haptoglobin, and Beta-2-Microglobulin. It is intended to simulate human patient samples for the purpose of monitoring the precision of laboratory testing procedures for Immunoglobulin E (IgE), Immunoglobulin M (IgM), Immunoglobulin G (IgG), Immunoglobulin A (IgA), Prealbumin, Antithrombin III, Alpha-1-Antitrypsin (AAT), Albumin, Complement C4 (C4), Complement C3 (C3), alpha-2-Macroglobulin, Alpha-1-Acid Glycoprotein, Ceruloplasmin, Transferrin, Haptoglobin, and Beta-2-Microglobulin assays. When used for quality control purposes, it is recommended that each laboratory establish its own means and acceptable ranges and use the values provided only as guides. The product is intended for use with quantitative assays on Beckman Image 800.
{1}
The Audit® MicroLQ™ Serum Protein Control is for In Vitro Diagnostic use only.
2. Indication(s) for use:
Same as Intended Use
3. Special conditions for use statement(s):
None
4. Special instrument requirements:
Performance was established on the Beckman Immage 800 analyzer.
I. Device Description:
The Audit® MicroLQ™ Serum Protein Control is a human serum-based protein control mixture. The base matrix is human serum. This is the starting matrix for building the two sets of controls: Low (Level 1) and High (Level 2) Controls. Both sets of controls contain the following analytes: Immunoglobulin E (IgE), Immunoglobulin M (IgM), Immunoglobulin G (IgG), Immunoglobulin A (IgA), Prealbumin, Antithrombin III, Alpha-1-Antitrypsin (AAT), Albumin, Complement C4 (C4), Complement C3 (C3), alpha-2-Macroglobulin, Alpha-1-Acid Glycoprotein, Ceruloplasmin, Transferrin, Haptoglobin, and Beta-2-Microglobulin. The Level 1 set contains lower levels of each analyte (except for beta-2-microglobulin) and the Level 2 set contains higher levels of each analyte.
The product is kitted as bi-level control with three 2-mL vials for each level, for a total of 6 vials.
J. Substantial Equivalence Information:
1. Predicate device name(s) and 510(k) number(s):
Audit® MicroCV™ Protein Linearity Set, k101216
2. Comparison with predicate:
| Similarities | | |
| --- | --- | --- |
| Item | Device | Predicate |
| Intended Use | Assayed QC material | Same |
| Analytes | Includes Alpha-1-antitrypsin, Complement C3, Complement C4, Immunoglobulin G, Immunoglobulin M, Immunoglobulin A, Transferrin | Same |
| Matrix | Human serum-based | Same |
| Storage | 2-8°C | Same |
| Form | Liquid | Same |
{2}
| Differences | | |
| --- | --- | --- |
| Item | Device | Predicate |
| Analytes | Includes Immunoglobulin E, Prealbumin, Antithrombin III, Albumin, Alpha-2-Macroglobulin, Alpha-1-Acid Glycoprotein, Ceruloplasmin, Haptoglobulin, and Beta-2-Microglobulin | These analytes are not included |
| | | |
| Type of Control | Bi-level control | Linearity set (5 levels) |
K. Standard/Guidance Document Referenced (if applicable):
None referenced
L. Test Principle:
Not applicable
M. Performance Characteristics (if/when applicable):
1. Analytical performance:
a. Precision/Reproducibility:
Not applicable
b. Linearity/assay reportable range:
Not applicable
c. Traceability, Stability, Expected values (controls, calibrators, or methods):
Traceability
The analytes used in this control material are human derived materials obtained from commercial vendors and QC tested in-house.
Value assignment
Each analyte value assignment for Level 1 and Level 2 was performed on the Beckman Immage 800 analyzer. All 16 analytes have been cleared for use with the Beckman Immage analyzer. Each analyte was measured 15 times (over a three-day period) and the mean value of each analyte was used to establish target concentration values at each level. The target ranges were calculated as $\pm 15\%$ of the target value. Expected value ranges for Level 1 and Level 2 of each analyte are shown in the table below. There is no Level 1 value for Beta-2-Microglobulin.
{3}
| Assay/Reagent | Units | Level 1 | | Level 2 | |
| --- | --- | --- | --- | --- | --- |
| | | Mean | Range | Mean | Range |
| Immunoglobulin E | IU/mL | 231 | 196-265 | 573 | 487-659 |
| Immunoglobulin M | mg/dL | 106 | 90-122 | 328 | 279-377 |
| Immunoglobulin G | mg/dL | 744 | 633-856 | 2081 | 1769-2394 |
| Immunoglobulin A | mg/dL | 267 | 227-307 | 644 | 547-740 |
| Prealbumin | mg/dL | 24.5 | 20.8-28.2 | 60.0 | 51.0-69.0 |
| Antithrombin III | mg/dL | 20.2 | 17.2-23.2 | 52.0 | 44.2-59.8 |
| Alpha-1-Antitrypsin | mg/dL | 97.5 | 82.9-112.2 | 250 | 212-287 |
| Albumin | mg/dL | 2377 | 2021-2734 | 6617 | 5625-7610 |
| Complement C4 | mg/dL | 19.9 | 16.9-22.9 | 55.3 | 47.0-63.6 |
| Complement C3 | mg/dL | 66.7 | 56.7-76.7 | 197 | 167-227 |
| alpha-2-Macroglobulin | mg/dL | 89.2 | 75.8-102.6 | 274 | 233-315 |
| Alpha-1-Acid Glycoprotein | mg/dL | 53.5 | 45.5-61.5 | 160 | 136-184 |
| Ceruloplasmin | mg/dL | 25.2 | 21.4-29.0 | 68.2 | 58.0-78.5 |
| Transferrin | mg/dL | 176 | 149-203 | 506 | 430-582 |
| Haptoglobin | mg/dL | 103 | 87-117 | 284 | 241-327 |
| Beta-2-Microglobulin | mg/L | N/A | N/A | 0.955 | 0.812-1.099 |
## Stability
A stability/shelf-life claim of 3 years at $2 - 8^{\circ}\mathrm{C}$ was determined based on an accelerated stability study on two lots of material. All vials that were used for stressed stability studies were first stressed in the incubator for 30 days, after which time the vials were opened, left at room temperature for 15 minutes, closed and left for 30 minutes at $2 - 8^{\circ}\mathrm{C}$. The percent loss was determined in comparison to Day Zero values and the product is considered stable when the loss reported is $\leq 15\%$ loss. Confirmatory real-time stability tests are ongoing.
There is no specific claim in the product labeling for on-board vial stability. After opening, the contents should be used according to the instrument manufacturer's instructions and immediately returned to $2 - 8^{\circ}\mathrm{C}$. The control material should not be left in the instrument and should be recapped and returned to the refrigerator after each use.
d. Detection limit:
Not applicable
e. Analytical specificity:
Not applicable
{4}
f. Assay cut-off:
Not applicable
2. Comparison studies:
a. Method comparison with predicate device:
Not applicable
b. Matrix comparison:
Not applicable
3. Clinical studies:
a. Clinical Sensitivity and Specificity:
Not applicable
b. Other clinical supportive data (when a. and b. are not applicable):
Not applicable
4. Clinical cut-off:
Not applicable
5. Expected values/Reference range:
Reference ranges for each analyte are supported by the scientific literature.
Expected values are provided in the labeling for each lot.
N. Proposed Labeling:
The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.
O. Conclusion:
The submitted information in this premarket notification is complete and supports a substantial equivalence decision.
5
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.
Sort by:
Create Alert
Search Filters
Agent Token
Create a read-only bearer token for Claude, ChatGPT, or other agents that can call HTTP APIs.
Copy this now. It will not be shown again.
Connected apps
Apps you authorized through browser sign-in. Disconnecting revokes their access immediately.
Learn the FDA Browser
Two short videos show you everything — or skip straight to the written tutorial if you'd rather read. You can reopen this any time from the Tutorial button in the top bar.
Part 1 — Search, results, and everyday workflows 16 min
Part 2 — Embeddings: the galaxy map 3 min
1. Search: exact and fuzzy
Type a phrase like "coronary artery calcification" into the search box. You get two kinds of results. Exact results match the literal phrase — prefix searches work ("coronary artery calcificati") but suffix searches do not. Fuzzy results match on the meaning and intent of your phrase rather than the exact words, and are sorted by relevance score. Hover over the Exact or Fuzzy badge on any row to see exactly why it matched.
Use the checkboxes above the results to narrow: SaMD keeps only software-only devices, AI / ML keeps only devices with AI.
Exact vs. fuzzy search: what's the difference?
Exact matches on the literal phrase (prefix search works, suffix does not). Fuzzy matches on the meaning and intent of the phrase rather than the exact words. Hover over the badge on any row to see why it matched.
You search "coronary artery calcification" and want only software devices with AI. What two filters do you apply?
Narrow by SaMD (software-only devices), then narrow by AI/ML (devices with AI).
2. The results table
Scroll right in the results table. The intended use is extracted for you — no need to open the PDF. The device story gives a high-level snapshot of what the device does and how it's used. The AI Performance sub-table shows each output name, acceptance criteria, observed values, and development/test dataset descriptions — the same format Innolitics uses for regulatory strategy outputs, and the fastest high-level fingerprint of an AI device. It is AI-generated but has been very reliable in practice.
Where do you find a device's intended use without opening the PDF?
Scroll right in the search results table. The intended use column is extracted for you; no need to dig into the 510(k) summary PDF.
What does the AI Performance sub-table show, and why is it useful?
Output name, acceptance criteria, observed values, development dataset description, and test dataset description. It's the same format we use for regulatory strategy output and Fast 510(k) input, and the fastest high-level fingerprint of an AI device. AI-generated but reliable in practice.
3. Judging fuzzy relevance
Fuzzy results trail off in relevance as you scroll. Use three signals to decide how far down to go: the fuzzy badge explanations, the intended use column, and whether your target output (e.g., Cobb angle) still appears in the AI Performance sub-table. Once it stops appearing, you're past the relevant zone. A top hit with a low score (~0.4) and a stretched explanation is a hint the closest predicates are far away — the project may be headed for De Novo. Note the fuzzy search is a pattern match: it doesn't handle negation ("not") well, and hardware devices can appear — filter by SaMD/AI ML to cut them.
How do you judge how far down fuzzy search results to go?
Use the relevancy signals: the fuzzy badge explanations, the intended use column, and whether the target output (e.g., Cobb angle) still appears in the AI Performance sub-table. Once it stops appearing, results are trailing off in relevancy.
4. Device detail page: chat and citations
Click a device name to open its detail page: device facts on the left, a chat window on the right. Ask something like "Describe the training data". The answer carries little citation bubbles — click one to jump to the highlighted passage in the source PDF, so you can verify every AI answer against the document. There's also a Download PDF button for sharing.
How do you verify an AI chat answer on the device detail page?
Click the citation bubbles to jump to the relevant highlight in the source document.
Reading rule for every project: how many summaries do you read in full?
At least the three most relevant 510(k) or De Novo summaries, in full. After that, use targeted chat questions to confirm your memory quickly. The tool supports this professional habit — it doesn't replace it.
5. Side-by-side comparison
Select multiple rows in the results table (aim for under ~10), then open the PDF Viewer tab. Ask one question — it goes to all selected devices in parallel, each with citations. This is the fastest way to compare and contrast devices: training data, PCCP scope, how they handled adding new scanners, and so on.
What does the side-by-side PDF viewer mode do?
Select multiple devices, open the PDF viewer tab, and ask one question (e.g., "Describe the training data"). It queries all selected devices simultaneously with citations, so you can compare and contrast quickly.
6. Collections
With rows selected, go to the Collections tab and create a labeled collection (e.g., "Cobb Angle Project"). Reload that selection any time — before a client call, pull up the collection and ask questions across all of its devices at once.
How do you save a set of selected devices for later use?
Select the rows, go to the Collections tab, and create a labeled collection (e.g., "Cobb Angle Project"). You can reload the selection anytime and carry it into the PDF viewer and other tabs that support selections.
7. Product codes and the regulations tree
Click a product code in the results to jump to it in the regulations tree — identification text, sibling product codes, and devices you can open in a PDF viewer on the right. Click a regulation number to see its identification, special controls, and related product codes. You can also search by product code or regulation number at the top of the tree. Always read the special controls if any exist for your device — it broadens your search and sharpens pre-kickoff research.
What can you do from the regulations tree view?
Browse product codes and regulation numbers, read the identification text and special controls, browse sibling product codes, open device PDFs on the right, and search by product code or regulation number at the top of the tree.
8. Chart view
Click Show Chart and segment by regulation number (or product code) to see which regulations dominate your result set. Clicking a regulation takes you into the regulations tree. Great for spotting that most matches are, say, hardware laparoscopic devices — a cue to go back and filter.
How do you see which regulations dominate a search result set?
Click "Show Chart" and segment by Regulation Number. Clicking a regulation takes you to the regulations tree.
9. The predicate graph
Open the Predicates tab for a family-tree view of predicate relationships. Click a node to trace its parents and children; selections from search carry over pre-selected. Commonly predicated devices are worth reading — a lot of people predicated them for a reason. The visual lineage is also handy on client calls, e.g. to show how a predicate family evolved and justify why your predicate still holds.
In the predicate graph, why are commonly predicated devices worth reading?
A lot of people predicated them for a reason. Clicking a node traces parents and children, and selections from search carry over pre-selected.
10. Embeddings: the galaxy map
The Embeddings tab plots every matching document in a 2-D "galaxy map" where semantically similar devices cluster together. Hover or click clusters to explore, and let AI label the clusters for you. Embeddings beat product codes for grouping: two devices can carry different product codes (LLZ vs. QIH) yet do the same thing — the embedding captures the meaning of the intended use and device story. This is also exactly how retrieval-augmented generation (RAG) works under the hood, and it makes a great visual on client calls.
Try it yourself
Head to the search page and work through a few of these AI/ML fuzzy searches to build intuition: perivascular fat on CT · aortic valve calcification opportunistic screening on noncontrast CT · breast cancer prediction on digital pathology slides · autism detection · gestational age prediction · a hearing aid that can also detect a pulse · foundation model based analysis of ECG · large language models · penetration test. Watch how the relevance scores, intended use, and AI Performance tables tell you when results stop being meaningful.
